Advancing TIL Clinical Development by Generating Early Efficacy Signals in Cold Solid Tumors
- Demonstrating initial clinical feasibility of TIL therapy in colorectal and prostate cancer
- Exploring patient selection and tumor sourcing challenges in low immunogenic indications
- Translating early treatment experience into future trial design decisions